P125 IL-36 Axis Is an Emerging Therapeutic Target in Psoriatic Arthritis Synovial Tissue

doi 10.1136/annrheumdis-2018-ewrr2019.113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Synovial IL‐17A+ CD8+ T Cells Display a Polyfunctional, Pro‐inflammatory and Tissue‐resident Memory Phenotype and Function in Psoriatic Arthritis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2020English

Pericytes in Cerebrovascular Diseases: An Emerging Therapeutic Target

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

CDK12: An Emerging Therapeutic Target for Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2018English

Adhesion Molecule Expression in the Synovial Membrane of Psoriatic Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Iron Metabolism: An Emerging Therapeutic Target in Critical Illness

Critical Care
Critical CareIntensive Care Medicine
2019English

IL-17 Producing Mast Cells Contribute to Synovial Inflammation in Non-Psoriatic and Psoriatic Spondyloarthritis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

IL-36 Signaling Is Essential for Psoriatic Inflammation Through the Augmentation of Innate Immune Responses

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Synovial Tissue Response to Treatment in Rheumatoid Arthritis

Open Rheumatology Journal
Rheumatology
2011English

Monocyte Chemotactic Factor in Rheumatoid Arthritis Synovial Tissue

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy